Penn State Investigators Pursue Diabetic Foot Ulcer Treatment & Capital for their Start up to Progress to Clinical Trials

Penn State Investigators Pursue Diabetic Foot Ulcer Treatment & Capital for their Start up to Progress to Clinical Trials

Led by Patricia McLaughlin, professor of behavioral sciences, Penn State College of Medicine Researchers are utilizing a $200,000 grant to advance a topically applied therapy to treat diabetic foot ulcers. The goal: a safer, more effective and more economical treatment option for the over 4 million diabetic patients across America struggling with this condition. Amputations can result if left untreated. Co-investigators include Dr. Joseph Sassani, professor and vice chair for clinical affairs in the Department of Ophthalmology and professor of pathology and laboratory medicine, as well as Ian Zagon, a distinguished progressor of neural and behavioral sciences. TrialSite Investor Watch showcases the Penn State Spinoff ElkosRX LLC.

The Condition

Due to a difference in skin cell activity, diabetics often experience slower and insufficient healing of wounds, particularly on the foot. Current treatment options are costly, difficult to administer and rarely prevent progression of the disease. McLaughlin’s novel therapeutic—a topical therapy that can be easily applied by patients or caregivers in the home — aims to target the underlying cause of the disease. Pre-clinical studies sh...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee